Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
1 result
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Upfront riociguat and ambrisentan combination therapy for newly diagnosed pulmonary arterial hypertension: A prospective open-label trial.
J Heart Lung Transplant. 2022 May;41(5):563-567. doi: 10.1016/j.healun.2022.01.002. Epub 2022 Jan 10.
J Heart Lung Transplant. 2022.
PMID: 35090807
Clinical Trial.
Cite
Cite